aTYR PHARMA INC 4
4 · aTYR PHARMA INC · Filed Jan 6, 2016
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blake John T
Vice President, Finance
Transactions
- Award
Employee Stock Option (right to buy)
2016-01-04+5,038→ 5,038 totalExercise: $9.13→ Common Stock (5,038 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable, if at all, in 48 equal monthly installments upon the achievement of certain performance goals, which must be achieved by January 4, 2018, or such option will be subject to immediate forfeiture. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.